| Pharmaceutical active ingredients: |
| Benazepril HydrochlorideHydrochlorothiazide |
| Available forms, composition and doses of Lotensin Hctz: |
| Tablets; Oral; Benazepril Hydrochloride 10 mg; Hydrochlorothiazide 12.5 mgTablets; Oral; Benazepril Hydrochloride 20 mg; Hydrochlorothiazide 12.5 mgTablets; Oral; Benazepril Hydrochloride 20 mg; Hydrochlorothiazide 25 mgTablets; Oral; Benazepril Hydrochloride 5 mg; Hydrochlorothiazide 6.25 mg |
| Lotensin Hctz medical category: |
| Human:Angiotensin-Converting Enzyme inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sandoz |
| Related documents and information about Lotensin Hctz: |
| Lotensin Novartis prescribing information (PDF)Lotensin HCT prescribing information (PDF) |